SISAF
SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon. The company’s Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improve the stability, safety, and transfection efficiency of RNA. SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders a... nd is maximizing the potential of its technology through research partnerships. Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, it has fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.
SISAF
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Guildford, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.sisaf.com
Total Employee:
11+
Status:
Active
Contact:
+44 1483 912002
Email Addresses:
[email protected]
Total Funding:
28.63 M USD
Technology used in webpage:
SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Similar Organizations
Algologie
Algologie is the standard-setter in the field of natural skin care.
In’Oya
In’Oya is develops dermo-cosmetic products derived from a patented technology, without any side effects, intended for pigmented skin.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
STENDERS
STENDERS produces and sells showering, bathing, and body care products.
Subitec
Subitec is engaged in the production of microalgae biomass substances for the cosmetics and food additives industries.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vickers Venture Partners
Vickers Venture Partners investment in Series B - SiSaf
Vickers Venture Partners
Vickers Venture Partners investment in Series A - SiSaf
Croda International
Croda International investment in Corporate Round - SiSaf
XNSI Sisaf Holdings LLC
XNSI Sisaf Holdings LLC investment in Series A - SiSaf
Innovation Ulster
Innovation Ulster investment in Series A - SiSaf
Vickers Venture Partners
Vickers Venture Partners investment in Series A - SiSaf
Invest Northern Ireland
Invest Northern Ireland investment in Series A - SiSaf
Vickers Venture Partners
Vickers Venture Partners investment in Series A - SiSaf
Vickers Venture Partners
Vickers Venture Partners investment in Series A - SiSaf
XNSI Sisaf Holdings LLC
XNSI Sisaf Holdings LLC investment in Series A - SiSaf
Official Site Inspections
http://www.sisaf.com
- Host name: 199.16.173.142
- IP address: 199.16.173.142
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SiSaf"
ABOUT US - SiSaf Ltd
During SiSaf’s foundational years a small team worked on developing and optimising the new hybrid technology and generating safety and efficacy data. These data enabled SiSaf in 2016 to secure Series A funding to pivot from a …See details»
SiSaf - Crunchbase Company Profile & Funding
SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research …See details»
Member profile: SiSaf Ltd | BIA
Led by founder and leading biomaterials specialist Dr. Suzanne Saffie-Siebert, SiSaf is a venture capital-backed private company. Headquartered in Guildford, UK, it has fully integrated …See details»
SiSaf - Contacts, Employees, Board Members, Advisors & Alumni
Organization. SiSaf . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of Board Member and …See details»
SiSaf Ltd - Leadership Team - The Org
The Leadership Team at SiSaf Ltd is responsible for setting the strategic direction of the company, overseeing its operations, and ensuring alignment across various functions. …See details»
SiSaf Ltd - The Org
SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of …See details»
RNA Delivery and Therapeutics Company SiSaf …
Sep 20, 2022 SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research and commercial partnerships. Led by founder and leading …See details»
SiSaf Company Profile - Office Locations, Competitors, Revenue
SiSaf Summary. Company Summary. Overview. SiSaf is a drug development company. It provides ProSilic, a biodegradable hybrid of porous silicon and liposomes designed to take …See details»
SiSaf – Surrey Research Park
Jan 18, 2023 Contact Us. Surrey Research Park Office, Surrey Technology Centre, 40 Occam Road, Guildford, Surrey, GU2 7YG. T: +44 (0)1483 502003 E: [email protected]See details»
SiSaf - Company info. interviews, news - biopharmatrend.com
May 16, 2023 FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment May 16, 2023 In a noteworthy development in the pharmaceutical …See details»
SiSaf Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for SiSaf. See SiSaf company profile and funding data.See details»
SiSaf CEO and Key Executive Team | Craft.co
SiSaf's Chairwoman & Chief Executive Officer is Suzanne Saffie-Siebert. Other executives include Michael Welsh, Chief Scientific Officer; Richard Scarrott, Chief Financial Officer and 8 …See details»
Sisaf - 2025 Company Profile - Tracxn
Aug 17, 2021 Sisaf is a series B company based in Belfast (United Kingdom), founded in 2006 by Suzanne Saffie Siebert. It operates as a Provider of drug delivery nano silicon-based drug …See details»
SiSaf Ltd. - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
SiSaf's silicon stabilized hybrid lipid nanoparticles (sshLNPs) ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early …See details»
SiSaf Ltd Announces US$13.2 Million Series B Financing
Nov 26, 2020 SiSaf Ltd announced today that it has raised US$13.2 million in Series B financing. This funding round was led by Vickers Venture Partners and matched by the UK …See details»
Sisaf | VentureRadar
Sisaf's proprietary technology represents a highly effective, non-irritant carrier for cosmetics and medical products, where improved skin penetration, targeting, and controlled release are …See details»
PIPELINE - SiSaf Ltd
SiSaf is developing a growing pipeline of RNA therapeutics, with a focus on oncology. Our lead program is a microRNA treatment of solid tumors, with the first indication being pancreatic …See details»
Designation of Viv Ansanm and Gran Grif
4 days ago The United States remains committed to protecting our national security interests and dismantling violent criminal gangs terrorizing the Haitian people. Today, the Department of …See details»
News & Events - SiSaf Ltd
SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis 12 SEPTEMBER 2022 READ MORE . RNA Therapeutics …See details»
Our Enabling Technology - SiSaf Ltd
SiSaf’s Bio-Courier technology addresses the challenges of lipid nanoparticles by stabilizing both lipids and RNA through a bioabsorbable silicon matrix. Silicon’s positive charge and high ζ …See details»